Device surveillance office
This article was originally published in The Gray Sheet
Executive Summary
Becomes operational June 28 following approval by FDA Commissioner David Kessler the week of June 21. The new office of surveillance and biometrics (formerly referred to as the postmarket management office) is being led by Jane Arrowsmith- Lowe, who was previously a medical officer in the FDA drug center's division of antiviral drug products. In addition to the director's office, OSB is comprised of an "issues management staff" and three divisions: the division of surveillance systems, the division of postmarket clinical evaluation, and the division of biometric sciences. As anticipated, most of OSB's personnel come from the device center's office of compliance and surveillance and office of science and technology ("The Gray Sheet" May 24, p. 6). Concurrent with formation of the new office, OCS has been renamed the office of compliance.
You may also be interested in...
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.
Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States
Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.